Crow's Feet Market Outlook Signals Expansion To $6.17 Billion Through 2030

The market for crow's feet treatments is on track for significant expansion in the coming years, driven by various advancements and changing consumer preferences. This report delves into the market size projections, key players, emerging trends, and segmentation details that define this evolving sector focused on reducing the appearance of fine lines around the eyes.

Projected Market Size and Growth of the Crow's Feet Industry
The crow's feet market is forecasted to experience steady growth, reaching a valuation of $6.18 billion by 2030. This translates to a compound annual growth rate (CAGR) of 7.5% over the period. The market's expansion is fueled by innovations in injectable cosmetic treatments, a growing number of men embracing skincare routines, personalized skincare advancements, higher disposable incomes, and a strong preference for minimally invasive procedures. Key trends shaping the market include increased adoption of non-invasive anti-aging therapies, wider use of botulinum toxin treatments, the popularity of at-home skincare devices, the rapid growth of dermatology and aesthetic clinics, and heightened focus on preventive skin aging care.

The crow's feet market size has grown strongly in recent years. It will grow from $4.29 billion in 2025 to $4.63 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to aging population growth, increased cosmetic awareness, availability of topical anti-aging products, celebrity influence, expansion of aesthetic medicine.

Download a free sample of the crow's feet market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21161&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Driving the Crow's Feet Market
Several top players dominate this market segment, including Procter & Gamble, Johnson & Johnson, AbbVie Inc., L'Oréal S.A., Sinclair Pharma plc, Ipsen Pharma, Clarins, Merz Pharma GmbH & Co. KGaA., Vichy Laboratoires, Obagi Cosmeceuticals LLC, Isdin, Hugel Inc., Evolus Inc., Revance Therapeutics Inc., Solta Medical Inc., Peter Thomas Roth Labs LLC, Ortho Dermatologics, SkinMedica Inc., Oxygenetix, Algenist, Lumenis Be Ltd., SkinCeuticals, and Solawave.
A notable development occurred in August 2024, when L'Oréal S.A., a cosmetics giant from France, acquired a 10% stake in Galderma Group AG for $1.85 billion from Sunshine SwissCo AG. This strategic move aims to merge Galderma's dermatological expertise with L'Oréal's advanced skin biology knowledge, diagnostic tools, and evaluation techniques, thereby accelerating innovation in aesthetic and skincare treatments focused on crow's feet. Galderma, based in Switzerland, specializes in dermatology solutions for this specific area.

Emerging Trends in the Crow's Feet Market That Shape Consumer Choices
A growing focus on non-invasive, effective, and convenient solutions is pushing companies to develop red and infrared light therapy masks targeted at reducing fine lines and wrinkles around the eyes. These devices use specific light wavelengths to stimulate collagen production, which helps diminish the visible signs of aging.
For instance, in October 2024, Solawave, a US-based skincare technology firm, introduced the Eye Recovery Pro, a mask combining red, deep red, near-infrared, and amber light therapies. Designed to combat early eye-area aging symptoms such as crow's feet, puffiness, "11" lines, dark circles, eyelid sagging, and uneven skin tone, this product promises noticeable improvements when used for three minutes, three times per week over a few weeks.

View the full crow's feet market report:
https://www.thebusinessresearchcompany.com/report/crows-feet-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Segments within the Crow's Feet Market Report
The report categorizes the crow's feet market into several primary segments:
1) Treatment Type: including Topical Creams, Botulinum Toxin (Botox), Chemical Peels, Dermal Fillers, and Other Treatment Types
2) Application Areas: covering Hospitals and Clinics, Dermatology Centers, Homecare, and other uses
3) Distribution Channels: such as Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

Further subsegments break down each treatment type into more specific categories:
- Topical Creams include Retinoids, Peptides, Antioxidants, Hyaluronic Acid-based Creams, and Alpha and Beta Hydroxy Acids (AHAs and BHAs)
- Botulinum Toxin treatments are divided into OnabotulinumtoxinA, AbobotulinumtoxinA (Dysport), IncobotulinumtoxinA (Xeomin), and PrabotulinumtoxinA (Jeuveau)
- Chemical Peels are classified as Superficial, Medium, or Deep peels
- Dermal Fillers include Hyaluronic Acid, Collagen-based, Poly-L-Lactic Acid (Sculptra), and Calcium Hydroxylapatite (Radiesse) fillers
- Other treatments encompass Laser Resurfacing, Microneedling, Radiofrequency, Ultrasound Therapy (Ultherapy), and Surgical Options

This detailed breakdown offers a comprehensive understanding of the various approaches and channels shaping the crow's feet treatment market today and in the future.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.